NCT03583424
- Conditions
- Hematopoietic Cell Transplantation Recipient, Hemic and Lymphatic Diseases, Immune System Diseases, +22 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Clinical trial condition
Hematopoietic Cell Transplantation Recipient
Explore clinical trials studying Hematopoietic Cell Transplantation Recipient. Study availability and eligibility vary by location and protocol.
10 public trials
0 recruiting studies
Hematopoietic Cell Transplantation Recipient trial results
NCT01701986
- Conditions
- Hematopoietic Cell Transplantation Recipient, Hemic and Lymphatic Diseases, Hodgkin Disease, +13 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT01718743
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT02860039
- Conditions
- Hematopoietic Cell Transplantation Recipient, Infections, Influenza, +8 more
- Locations
-
- UCSF Children's Hospital San Francisco, California, United States
- Children's Mercy Hospital Kansas City, Missouri, United States
- Cincinnati Children's Hospital Cincinnati, Ohio, United States
- Nationwide Children's Hospital Columbus, Ohio, United States
NCT01927731
- Conditions
- Bone Marrow Transplantation Recipient, Cord Blood Transplant Recipient, Hematopoietic Cell Transplantation Recipient
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT03574012
- Conditions
- Acute Leukemia in Remission, Hematopoietic Cell Transplantation Recipient, Hemic and Lymphatic Diseases, +7 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT03267186
- Conditions
- Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +23 more
- Locations
-
- Stanford University, School of Medicine Palo Alto, California, United States
NCT03525106
- Conditions
- Hematopoietic Cell Transplantation Recipient
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Active, Not Recruiting
Elotuzumab and Lenalidomide After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma
NCT02420860
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
NCT00736749
- Conditions
- Hematologic Diseases, Hematopoietic Cell Transplantation Recipient, Hemic and Lymphatic Diseases, +4 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- USA Health Strada Patient Care Center Mobile, Alabama, United States
- Phoenix Childrens Hospital Phoenix, Arizona, United States